HighQC™ Human IPS Cell (IPSC From PBMC/ Parkinson/ Episomal)

Description

HighQC™ Human iPSCs (iPSC From PBMC/ Parkinson/ Episomal) are induced pluripotent stem cells derived from peripheral blood mononuclear cells (PBMCs) of a Parkinson’s disease (PD) patient. The cells display a typical round colony morphology with small, tightly packed cells. The PBMCs were reprogrammed through episomal delivery of transcription factors OCT4, SOX2, KLF4, and c-MYC, thereby ensuring genomic integrity without viral integration. These cells exhibit high expression of pluripotency markers, including NANOG and SSEA-4, and possess robust differentiation potential into midbrain dopaminergic neurons, enabling disease-relevant modeling. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.